Comprehensive investigation of the clinical significance of long non-coding RNA HOXA-AS2 in acute myeloid leukemia using genome-wide RNA sequencing dataset

Conclusion: Our findings suggest that HOXA-AS2 is up-regulated in the bone marrow in patients with AML, and may serve as a novel prognostic biomarker for AML.

Source: Journal of Cancer - April 19, 2021 Category: Cancer & Oncology Authors: Rui Huang, Xiwen Liao, Xiangkun Wang, Qiaochuan Li Tags: Research Paper Source Type: research